Is Aemetis Inc (AMTX) overvalued? · rev $77.2M
Aemetis Inc (AMTX) is a specialty chemicals company listed on US.
This page asks whether Aemetis Inc (AMTX) looks expensive on cached numbers — not a short thesis.
Latest reported AMTX revenue for 2023-12-31 was $77.2M. Net income was -$46.4M. Revenue was up 174.6% from 2022-12-31 to 2023-12-31. AMTX currently screens at market cap $158.3M.
AMTX currently screens at market cap $158.3M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AMTX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AMTX stock page for the full model, not this heading.
Not investment advice.